Vascular Endothelial Growth Factor as an Autocrine Survival Factor for Retinal Pigment Epithelial Cells under Oxidative Stress via the VEGF-R2/PI3K/Akt
Open Access
- 1 February 2010
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 51 (2), 1190-1197
- https://doi.org/10.1167/iovs.09-4144
Abstract
Purpose.: Vascular endothelial cell growth factor (VEGF) is strongly induced by oxidative stress in retinal pigment epithelial (RPE) cells, and VEGF-A is a survival factor for various cell types. This study was conducted to determine whether the autocrine VEGF signaling pathway in RPE cells is involved in the mechanism of adaptive response to oxidative stress. Methods.: ARPE-19 cells were treated with hydrogen peroxide, and cell death was measured by flow cytometry with annexin V-fluorescein isothiocyanate. Survival analysis was performed with pretreatment of VEGF-A–neutralizing antibodies, VEGF receptor tyrosine kinase inhibitor (SU5416), or VEGF-A receptor-neutralizing antibodies (anti-VEGF-R1 and anti-VEGF-R2). The expression of VEGF-A, -R1, -R2, and soluble VEGF-R1 was determined by semiquantitative RT-PCR or Western blot analysis. Phosphorylation of VEGF-R2 was detected with immunoprecipitation and immunoblot analysis. Results.: Hydrogen peroxide–induced cell death was promoted by pretreatment with VEGF-A and anti-VEGF-R2–neutralizing antibodies, but not with anti-VEGF-R1–neutralizing antibody. Phosphorylation of VEGF-R2 in RPE cells was induced by hydrogen peroxide, and pretreatment with anti-VEGF-A–neutralizing antibody inhibited phosphorylation. Phosphorylation of Akt under oxidative stress was abrogated by pretreatment with neutralizing antibodies against either VEGF-A or SU5416. Conclusions.: Autocrine VEGF-A enhanced RPE cell survival under oxidative stress; the autocrine VEGF-A/VEGF-R2/PI3K/Akt pathway is involved. Neutralization of VEGF-A signaling, as in eyes with age-related macular degeneration, may influence RPE cell survival.This publication has 35 references indexed in Scilit:
- Vascular endothelial growth factor in eye diseaseProgress in Retinal and Eye Research, 2008
- Anti-Angiogenic Effects of Ribonucleic Acid Interference Targeting Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor-1αAmerican Journal of Ophthalmology, 2007
- Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1PLoS Medicine, 2007
- Oxidant-mediated Akt Activation in Human RPE CellsInvestigative Ophthalmology & Visual Science, 2006
- Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disordersGene Therapy, 2005
- Fetal Stromal–Dependent Paracrine and Intracrine Vascular Endothelial Growth Factor-A/Vascular Endothelial Growth Factor Receptor-1 Signaling Promotes Proliferation and Motility of Human Primary Myeloma CellsCancer Research, 2005
- A Novel Role for Vascular Endothelial Growth Factor as an Autocrine Survival Factor for Embryonic Stem Cells during HypoxiaOnline Journal of Public Health Informatics, 2005
- RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF.Investigative Ophthalmology & Visual Science, 2003
- Vascular Endothelial Growth Factor Family and Receptor Expression in Human Choroidal Neovascular MembranesMicrovascular Research, 2002
- Increased expression of angiogenic growth factors in age-related maculopathyBritish Journal of Ophthalmology, 1997